← Eichor
Condition: Partial Onset Seizures Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Partial Onset Seizures

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety, Efficacy, and PK of ONO-2017 in Japanese Patients With POS 2 to 17 Year Olds
Phase 3 · 1 location(s) · Ono Pharmaceutical Co., Ltd. · NCT07594158RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Phase 2 · 1 location(s) · Supernus Pharmaceuticals, Inc. · NCT06798896A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Phase 2 · 7 location(s) · Rapport Therapeutics Inc. · NCT07219407A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Phase 2/Phase 3 · 124 location(s) · Biohaven Therapeutics Ltd. · NCT06132893SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Phase 2 · 1 location(s) · Supernus Pharmaceuticals, Inc. · NCT07141329Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
Phase 2 · 29 location(s) · Ono Pharmaceutical Co., Ltd. · NCT06590896A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized T
Phase N/A · 1 location(s) · Eisai Co., Ltd. · NCT06657378
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.